» Articles » PMID: 12482154

Post-transplant Lymphoproliferative Disorder in the United States: Young Caucasian Males Are at Highest Risk

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2002 Dec 17
PMID 12482154
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously documented Caucasian race and cadaver donor source as risk factors for post-transplant lymphoproliferative disorder (PTLD) development in recipients registered in the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). We analyzed data from the Scientific Registry of the United Network of Organ Sharing (UNOS) (from January 1988 to December 1999) to determine risk factors for the development of PTLD in all organ systems and its frequency, and we compared these factors to the risk factors in the most recent NAPRTCS database (1987-2000). In the UNOS database, PTLD was reported in 2365 of 205114 organ-transplant recipients (1.2%). PTLD was reported in 3% or more of all intestinal and thoracic organ recipients, but in less than 1% of other abdominal organ recipients. Recipient age < 18 years, Caucasian race and male gender were independent risk factors [Odds Ratios (OR) 2.81, 2.22 and 1.40, respectively, p = 0.0001], but not cadaver donor source. The combination of all three risk factors increased the OR to 8.78. The occurrence of PTLD showed a significant rise per year for heart-lung, kidney, kidney-pancreas and liver transplants, but decreased significantly for heart transplants (p < 0.001). Similar frequencies of PTLD were found in smaller organ-specific registries of heart, intestine, pediatric liver and pediatric kidney transplants. The PTLD incidence per year and incidence density have increased in recent years. Young Caucasian males are at highest risk for PTLD development among solid-organ-transplant recipients. The incidence of PTLD is increasing.

Citing Articles

Patterns of belatacept use and risk of post-transplant lymphoproliferative disorder in US kidney transplant recipients: An analysis of the Organ Procurement and Transplantation Network database.

Cherikh W, Kou T, Foutz J, Baker T, Gomez-Caminero A PLoS One. 2025; 20(1):e0311935.

PMID: 39792912 PMC: 11723631. DOI: 10.1371/journal.pone.0311935.


Elucidating the nexus between onco-immunology and kidney transplantation: An insight from precision medicine perspective.

Purnomo A, Nurkolis F, Syahputra R, Moon S, Lee D, Taslim N Heliyon. 2024; 10(13):e33751.

PMID: 39040404 PMC: 11261886. DOI: 10.1016/j.heliyon.2024.e33751.


Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States.

Tajima T, Martinez O, Bernstein D, Boyd S, Gratzinger D, Lum G Pediatr Transplant. 2024; 28(4):e14763.

PMID: 38682750 PMC: 11115376. DOI: 10.1111/petr.14763.


Pediatric Kidney Transplantation: Cancer and Cancer Risk.

Order K, Rodig N Semin Nephrol. 2024; 44(1):151501.

PMID: 38580568 PMC: 11734768. DOI: 10.1016/j.semnephrol.2024.151501.


Post-Transplant Lymphoproliferative Disorders.

Dharnidharka V, Ruzinova M, Marks L Semin Nephrol. 2024; 44(1):151503.

PMID: 38519279 PMC: 11213680. DOI: 10.1016/j.semnephrol.2024.151503.